SEC Form 4 · accession 0001479791-18-000003
INVO Bioscience, Inc. · IVOB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Claude Ranoux
10% Owner
Period of report
Jan 5, 2018
Accepted (ET)
Jan 5, 2018 · 4:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001417926
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| INVO Bioscience Common Stock | Jan 5, 2018 | S | 500,000 | $0.05 | D | 25,675,763 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
These 500,000 INVO Bioscience securities were sold to a private investor